查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1375862

綜合代謝組測試市場規模、佔有率、趨勢分析報告：按分析項目、疾病、最終用途、地區和細分市場進行預測，2023-2030 年

Comprehensive Metabolic Panel Testing Market Size, Share & Trends Analysis Report By Analytes (K+, Na+, Cl-, CO2, Glucose), By Disease, By End-use (Laboratory, PoC), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

綜合代謝組測試市場成長與趨勢：

Grand View Research 的最新報告顯示，到 2030 年，全球綜合代謝組測試市場規模預計將達到 208.7 億美元。

預計2023年至2030年該市場將以9.1%的年複合成長率擴張。全球疾病負擔的增加和新診斷產品的出現推動了市場

慢性病盛行率的上升以及遏制醫療保健支出的需求日益成長，預計將增加對疾病早期診斷和定期監測的需求，從而推動 CMP 檢測市場的發展。生物晶片、微陣列和伴隨診斷等技術先進產品的推出正在推動對早期異常檢測的需求。 CMP 測試提供了一種經濟有效且節省時間的方法來評估 14 種分析物，以識別、診斷和監測多種疾病。

消費者對醫療保健的認知不斷提高是預計推動 CMP 測試市場的關鍵因素之一。世界各地的許多組織正在努力提高人們對這種疾病、可用治療方案以及早期診斷和預防措施的好處的認知。例如，國際糖尿病基金會和美國糖尿病協會透過多次宣傳活動和其他廣告方式，帶頭強調糖尿病診斷和監測的迫切需求。它們是一個團體的一部分。

在綜合代謝組測試市場中，由於產品價格有細微差異，消費者購買行為較為複雜。不同市場參與者提供的產品進行策略性定價，以增加競爭公司之間的對抗關係。隨著市場競爭變得更加激烈，消費者對改善診斷的需求，包括安全性、有效性、敏感性和特異性，預計將達到歷史最高水準。

近年來，隨著改進的診斷產品的推出和生物標記的引入，醫療診斷領域經歷了範式轉移。然而，復發和疾病進展仍然很高，特別是在老年人中。強烈的未滿足需求代表了在 CMP 測試領域開發創新的一流診斷技術的重要機會。

綜合代謝面板測試市場報告亮點

  • 腎臟疾病細分市場在 2022 年佔據最大銷售佔有率，達到 32.71%，該細分市場受到高疾病盛行率和分析物最大利用率的推動。
  • 預計糖尿病領域在預測期內將以 9.9% 的年複合成長率成長最快。近 50% 的糖尿病患者仍未被診斷，這為綜合代謝檢測市場創造了利潤豐厚的成長機會。
  • PoC 領域預計在預測期內將以 9.8% 的最快年複合成長率成長。 PoC CMP 測試的驅動力是易於操作、攜帶、快速獲得結果和低樣品要求。
  • 由於易於取得、市場滲透率高、使用量不斷增加以及具有臨床意義的結果，實驗室細分市場在 2022 年佔據了最高的銷售佔有率，達到 59.97%。
  • 受醫療基礎設施改善、更容易患慢性病的老年人數量增加、消費者意識增強、可支配所得增加以及整體經濟發展的推動，亞太地區在預測期內將以 11.7% 的年複合成長率成長。具有最高的成長。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 綜合代謝組測試市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 綜合代謝面板測試市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 綜合代謝組測試市場：分析估計/趨勢分析

  • 綜合代謝組測試市場：重點
  • 綜合代謝組測試市場：2022 年和 2030 年趨勢和市場佔有率分析
  • K+
  • 鈉+
  • Cl-
  • CO2
  • 葡萄糖
  • 貨車
  • 肌酸酐
  • Ca++
  • 白蛋白
  • 總蛋白
  • ALP
  • 選擇
  • AST
  • 總膽紅素

第5章 綜合代謝組檢測市場：疾病估計與趨勢分析

  • 綜合代謝組測試市場：重點
  • 綜合代謝組測試市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 腎臟疾病
  • 肝病
  • 糖尿病
  • 其他

第6章 綜合代謝組測試市場：最終用途估計與趨勢分析

  • 綜合代謝組測試市場：重點
  • 綜合代謝組測試市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 實驗室
  • 示範實驗
  • 概念驗證（設備）

第7章 綜合代謝組檢測市場：區域估算與趨勢分析

  • 區域展望
  • 按地區分類的綜合代謝面板測試市場：主要市場點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Abbott
    • Quest Diagnostics
    • Laboratory Corporation of America Holdings
    • Sonic Healthcare Limited
    • Unipath
    • SYNLAB International GmbH
    • ARUP Laboratories
    • Genoptix Inc.
    • Nova Biomedical
Product Code: GVR-3-68038-747-6

Comprehensive Metabolic Panel Testing Market Growth & Trends:

The global comprehensive metabolic panel testing market size is expected to reach USD 20.87 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 9.1% from 2023 to 2030. The market driven by an increasing global disease burden and the emergence of novel diagnostic products.

Rising prevalence of chronic diseases coupled with increasing need to curb healthcare expenditure are expected to boost the CMP testing market by increasing the demand for early disease diagnosis and regular monitoring. Introduction of technologically advanced products, such as biochips, microarrays, and companion diagnostics, has driven the necessity for early detection of anomalies. CMP testing offers a cost-effective and time-saving method for evaluating 14 analytes for identification, diagnosis, or monitoring of several diseases.

Rising consumer awareness regarding healthcare is one of the major factors anticipated to drive the market for CMP testing. Many organizations worldwide are working toward increasing awareness pertaining to diseases, available treatment options, and benefits of early diagnosis and precautions. For instance, the International Diabetes Foundation and the American Diabetes Association are some of the key organizations that emphasize the urgent need for diagnosing and monitoring diabetes through several awareness campaigns and other modes of advertisement.

The buying behavior of consumers is moderately complex in the comprehensive metabolic panel testing market, due to subtle differences in product prices. The products offered by various market players have been strategically priced to increase competitive rivalry. As the market becomes increasingly competitive, consumer needs are anticipated to reach at an all-time high for improved diagnostics - in terms of safety, efficacy, sensitivity, and specificity.

The medical diagnostics landscape has undergone a paradigm shift over the last few years, driven by the launch of improved diagnostic products and introduction of biomarkers. However, recurrence and disease progression remain high, especially among geriatric patients. Strong unmet needs present a key opportunity to develop breakthrough first-in-class diagnostics in the CMP testing space.

Comprehensive Metabolic Panel Testing Market Report Highlights:

  • The kidney diseases segment accounted for the largest revenue share of 32.71% in 2022, and the segment is driven by a high disease prevalence and maximum utilization of analytes.
  • The diabetes segment is expected to grow at the fastest CAGR of 9.9% during the forecast period. Nearly 50% of diabetics remain undiagnosed, presenting a lucrative opportunity for growth for the comprehensive metabolic panel testing market.
  • The PoC segment is expected to grow at the fastest CAGR of 9.8% over the forecast period. The PoC CMP tests are driven by their ease of operation, portability, speed of results, and lesser requirement of the sample.
  • The laboratories segment accounted for the highest revenue share of 59.97% in 2022, driven by easy availability, high market penetration, increased usage, and clinically significant results.
  • Asia Pacific is expected to grow at the highest CAGR of 11.7% over the forecast period, driven by improvements in healthcare infrastructure, a rise in the number of older people, who are more susceptible to chronic illnesses, growth in consumer awareness, a rise in disposable income, and overall economic development.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Analytes
    • 1.1.2. Disease
    • 1.1.3. End use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Analytes outlook
    • 2.2.2. Disease outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Comprehensive Metabolic Panel Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Comprehensive Metabolic Panel Testing Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Comprehensive Metabolic Panel Testing Market: Analytes Estimates & Trend Analysis

  • 4.1. Comprehensive Metabolic Panel Testing Market: Key Takeaways
  • 4.2. Comprehensive Metabolic Panel Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. K+
    • 4.3.1. K+ market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Na+
    • 4.4.1. Na+ market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Cl-
    • 4.5.1. Cl- market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. CO2
    • 4.6.1. CO2 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Glucose
    • 4.7.1. Glucose market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. BUN
    • 4.8.1. BUN market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.9. Creatinine
    • 4.9.1. Creatinine market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.10. Ca++
    • 4.10.1. Ca++ market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.11. Albumin
    • 4.11.1. Albumin market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.12. Total Protein
    • 4.12.1. Total protein market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.13. ALP
    • 4.13.1. ALP market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.14. ALT
    • 4.14.1. ALT market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.15. AST
    • 4.15.1. AST market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.16. Total Bilirubin
    • 4.16.1. Total bilirubin market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Comprehensive Metabolic Panel Testing Market: Disease Estimates & Trend Analysis

  • 5.1. Comprehensive Metabolic Panel Testing Market: Key Takeaways
  • 5.2. Comprehensive Metabolic Panel Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Kidney Diseases
    • 5.3.1. Kidney diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Liver Diseases
    • 5.4.1. Liver diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Diabetes
    • 5.5.1. Diabetes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Comprehensive Metabolic Panel Testing Market: End-Use Estimates & Trend Analysis

  • 6.1. Comprehensive Metabolic Panel Testing Market: Key Takeaways
  • 6.2. Comprehensive Metabolic Panel Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Laboratories
    • 6.3.1. Laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.3.2. Emergency departments
      • 6.3.2.1. Emergency departments market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.3.3. Hospital wards
      • 6.3.3.1. Hospital wards market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.3.4. Primary care
      • 6.3.4.1. Primary care market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.3.5. Pharmacy
      • 6.3.5.1. Pharmacy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.3.6. Telemedicine
      • 6.3.6.1. Telemedicine market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. PoC
    • 6.4.1. PoC market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.2. Emergency departments
      • 6.4.2.1. Emergency departments market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.3. Hospital wards
      • 6.4.3.1. Hospital wards market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.4. Primary care
      • 6.4.4.1. Primary care market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.5. Pharmacy
      • 6.4.5.1. Pharmacy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.6. Telemedicine
      • 6.4.6.1. Telemedicine market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. PoC (Instruments)
    • 6.5.1. PoC market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.2. Piccolo Xpress
      • 6.5.2.1. Piccolo xpress market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.3. Skyla-HB1
      • 6.5.3.1. Skyla-HB1 market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.4. DRI-CHEM NX500
      • 6.5.4.1. DRI-CHEM NX500 market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.5. Others
      • 6.5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Comprehensive Metabolic Panel Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Comprehensive Metabolic Panel Testing Market by Region: Key Marketplace Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Denmark
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Abbott
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Quest Diagnostics
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Laboratory Corporation of America Holdings
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Sonic Healthcare Limited
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Unipath
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. SYNLAB International GmbH
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. ARUP Laboratories
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Genoptix Inc.
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Nova Biomedical
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 3 North America comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 4 North America comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 5 North America comprehensive metabolic panel testing market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 7 U.S. comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 8 U.S. comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 10 Canada comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 11 Canada comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Europe comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 13 Europe comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 14 Europe comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe comprehensive metabolic panel testing market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 17 Germany comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 18 Germany comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 20 UK comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 21 UK comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 22 France comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 23 France comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 24 France comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Italy comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 26 Italy comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 27 Italy comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Spain comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 29 Spain comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 30 Spain comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Denmark comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 32 Denmark comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 33 Denmark comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Sweden comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 35 Sweden comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 36 Sweden comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Norway comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 38 Norway comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 39 Norway comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific comprehensive metabolic panel testing market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 45 Japan comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 46 Japan comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 47 China comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 48 China comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 49 China comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 50 India comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 51 India comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 52 India comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Australia comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 54 Australia comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 55 Australia comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Thailand comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 57 Thailand comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 58 Thailand comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 59 South Korea comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 60 South Korea comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 61 South Korea comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Latin America comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 63 Latin America comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 64 Latin America comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America comprehensive metabolic panel testing market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 67 Brazil comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 68 Brazil comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Mexico comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 70 Mexico comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 71 Mexico comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Argentina comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 73 Argentina comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 74 Argentina comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa comprehensive metabolic panel testing market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 80 South Africa comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 81 South Africa comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 85 UAE comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 86 UAE comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 87 UAE comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 89 Kuwait comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 90 Kuwait comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Comprehensive metabolic panel testing: Market outlook
  • Fig. 8 Comprehensive metabolic panel testing: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Comprehensive metabolic panel testing market driver impact
  • Fig. 13 Comprehensive metabolic panel testing market restraint impact
  • Fig. 14 Comprehensive metabolic panel testing market strategic initiatives analysis
  • Fig. 15 Comprehensive metabolic panel testing market: Disease movement analysis
  • Fig. 16 Comprehensive metabolic panel testing market: Disease outlook and key takeaways
  • Fig. 17 Kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Liver diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Diabetes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Comprehensive metabolic panel testing market: Disease movement analysis
  • Fig. 22 Comprehensive metabolic panel testing market: Disease outlook and key takeaways
  • Fig. 23 K+ market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Na+ market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Cl- market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 CO2 market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Glucose market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 BUN market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Creatinine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Ca++ market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Albumin market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Total protein market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 ALP market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 ALT market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 AST market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Total bilirubin market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Comprehensive metabolic panel testing market: End-Use movement analysis
  • Fig. 38 Comprehensive metabolic panel testing market: End-Use outlook and key takeaways
  • Fig. 39 Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 PoC market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 PoC (instruments) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Global comprehensive metabolic panel testing market: Regional movement analysis
  • Fig. 43 Global comprehensive metabolic panel testing market: Regional outlook and key takeaways
  • Fig. 44 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)